Innovative Partnership Launches Advanced Pain Research Solution: Pain Cloud® Collaboration Between EptivA and Infopoly

EptivA Therapeutics and Infopoly Ltd. have launched Pain Cloud®, a novel in-silico method aimed at revolutionizing pain research. Pain Cloud leverages network biology to link open-access "omic" data with its Proprietary Pain Landscape®, which includes information on over 1,000 pain conditions. This approach, validated by a Bayer Pharmaceuticals collaboration, contrasts traditional animal and cell-culture methods, which often lack translation to human targets. The AI-powered platform promises to improve pain therapeutics R&D efficiency, addressing the 1% clinical development success rate and high costs, and potentially offering target validation for human pain mechanisms.